[1] Zhu, YM., Dai, Y., Tian, YC., Tian, Y. New peptide PROTAC is triggering a revolution in precise targeted skincare. 2023, Preprint.[2] Chen, S., Zheng, Y., Liang, B., Yin, Y., Yao, J., Wang, Q., Liu, Y. and Neamati N. The application of PROTAC in HDAC. Eur J Med Chem. 2023, 260:115746.[3] Weng G, Cai X, Cao D, Du H, Shen C, Deng Y, He Q, Yang B, Li D, Hou T. PROTAC-DB 2.0: an updated database of PROTACs. Nucleic Acids Res. 2023, 51(D1):D1367-D1372.[4] Han, D., Wang, L., Jiang, S. and Yang, Q. The ubiquitin-proteasome system in breast cancer. Trends Mol Med. 2023, 29(8), 599-621.[5] PROTAC technology: A new drug design for chemical biology with many challenges in drug discovery. Drug Discov Today. 2023, 28(1):103395.[6] Bou Ghanem GO, Koktysh D, Baratta RO, Del Buono BJ, Schlumpf E, Wareham LK, Calkins DJ. Collagen Mimetic Peptides Promote Repair of MMP-1-Damaged Collagen in the Rodent Sclera and Optic Nerve Head. Int J Mol Sci. 2023, 24(23):17031.[7] 庞树朝，陈美玲，张军平．基于AMPKα/mTOR/p70S6K通路探讨补肾抗衰片类脂联素受体激动剂样作用干预人主动脉平滑肌细胞增殖的机制［J］．中华中医药杂志，2023,38(10):4711-4716.[8] 郑文婕，童坦君，张宗玉．细胞衰老的重要通路：p16~(INK4a)/Rb和p19~(ARF)/p53/p21~(Cip1) 信号途径［J］．生命的化学，2002,(04):314-316.[9] 闫海龙，龚勇珍．氧化应激及p16和p53/p21与细胞衰老关系的研究进展［J］．医学综述，2011,17(05):682-685.[10] 栗瑞斌，王倩，张雷杰，等．负载酪氨酸酶抑制肽的牛奶外泌体抑制酪氨酸酶活性及黑色素生成研究［J］．天津医科大学学报，2022,28(04):348-352+371.[11] 朱翠翠．调节黑色素生成的主要信号通路［J］．日用化学品科学，2023,46(07):61-70.）[12] 唐卓，付丁强，袁奕，等．靶向降解酪氨酸酶的PROTAC及其应用［P］．四川省，2023,CN202111043833.2.[13] 蒋卓育，王宇嘉，张悦，等．IL-6/IL-6R 抑制剂在免疫炎症性皮肤疾病的应用［J］．中国麻风皮肤病杂志，2024,40(02):145-149.[14] Yixi Y ,Yujin Z ,Xun C , et al.Khasianine ameliorates psoriasis-like skin inflammation and represses TNF-α/NF-κB axis mediated transactivation of IL-17A and IL-33 in keratinocytes.［J］．Journal of ethnopharmacology,2022,292115124-115124.[15] Tengfei X ,Mingzhong S ,Chuanxiang Z , et al.TRPV1: A promising therapeutic target for skin aging and inflammatory skin diseases［J］．Frontiers in Pharmacolo gy,2023,141037925-1037925.[16] 高晶，杨镭，雷书敏，等．用于精准蛋白降解和癌症治疗的刺激响应型PROTAC进展（英文）［J］．Science Bulletin,2023,68(10):1069-1085.